At a Glance

Regime: Bounce · Open: Flat · Risk on new positions: High · Custom T2108: 42.6, falling

Focus: SMWB (Earnings Catalyst · Duration) · SLS (Biotech Catalyst · Magnitude)

Secondary: N/A

Tonight After Hours: CAAP, DLB, GLAD, NVDA★ · Tomorrow Before Open: BRBR, GLBE, JJSF, LOW, TGT★, ZIM · ★ = Market Mover

Holding: DCTH, CGON

Situational Awareness

Market Condition: Bounce

Commentary: Slight green open today in the market. VIX is down, which is a positive. Nothing is exactly mind-blowing about the market right now.

We have Nvidia after hours, with some AI names, particularly optics names, bouncing. Given yesterday’s down day, this shouldn’t be a surprise. Less is more still.

We have two picks today that look like they have potential. Caution is warranted; we could see a higher low, or we could simply be experiencing a pause day before a further decline.

Nvidia earnings are very important this evening. I expect the numbers to be good, but the commentary, especially regarding funding for neo clouds, will likely be more significant. Their guidance will be crucial; a reiteration would be reassuring, while pulling guidance or indicating problems would be a major negative for the market.

We also have the Anthropic IPO on Thursday, and I expect a bounce. Strong investor demand suggests that better-than-expected Nvidia earnings tonight could spark a market bounce that carries into the Anthropic IPO. Either way, conditions are relatively poor for us, with few catalysts and limited follow-through trading.

That’s all for today. Picks are below.

Today In Focus

SMWB — Similarweb: Earnings Beat & Raised Guidance, Positive GAAP Inflection

Earnings Catalyst · Duration · Mkt cap $685.0M · Float 52M · SI 1.1% (1.6 days) · NYSE · Theme: Software - Application · Next earnings N/A

Why: Strong Earnings and Guidance, Positive GAAP Inflection. Solid Chart.

Level: $9

SLS — SELLAS Life Sciences: Positive Pivotal Phase 3 REGAL Data — Cancer Vaccine GPS Shows Statistically Significant Overall Survival Improvement in AML

Biotech Catalyst · Magnitude · Mkt cap $1.5B · Float 201M · SI 28.3% (6.7 days) · Nasdaq · Theme: Oncology > Cancer Therapies · Next earnings N/A

Why: Big headline for this: very high short interest. I’m seeing skepticism about the name on my biotech feed, mainly regarding the P values and claims that the numbers are a bit dodgy. However, a big move, a big headline, a cancer vaccine, and statistically significant, clinically meaningful results make it one to watch today.

There is already a huge gap up, currently sitting below the VWAP. I would be careful near the open, especially with such high short interest. Shorts tend not to cover immediately, but I don’t think you can ignore this today. Even if the company is doubted and there are data issues, it will likely be a short-term mover, and I would be wary of after-hours raises.

Level: Wait and See Approach. $30 is the Pre Market High Wall.

Also in Play

N/A

Charts to Watch

Catalyst Winners 2026: TradingView

Powerplay Watch: TradingView

Consolidation Watch: TradingView

Trade Updates

Open:

DCTH - Earnings Catalyst - 9th November 2026 - 67% Remaining
CGON - Biotech Catalyst - 16th November 2026 - 100% Remaining

Macro Events (Eastern Time)

Tuesday November 17 2026

8:30 AM - Retail Sales MoM (Oct) (Previous: 0.8%, Consensus: 0.2%)

8:30 AM - Retail Sales Ex Gas/Autos MoM (Oct) (Previous: 0.5%, Consensus: 0.3%)

8:30 AM - Retail Sales YoY (Oct) (Previous: 6.6%, Consensus: 6.5%)

8:30 AM - Retail Sales Ex Autos MoM (Oct) (Previous: 1.1%, Consensus: 0.4%)

8:30 AM - Retail Sales Control Group MoM (Oct) (Previous: 0.5%, Consensus: 0.4%)

8:30 AM - Export Prices MoM (Oct) (Previous: 2.4%, Consensus: 0.3%)

8:30 AM - Import Prices MoM (Oct) (Previous: 1.1%, Consensus: 0.7%)

9:15 AM - Industrial Production MoM (Oct) (Previous: 0.7%, Consensus: 0.1%)

10:00 AM - Business Inventories MoM (Sep) (Previous: 0.4%, Consensus: 0.5%)

10:00 AM - NAHB Housing Market Index (Nov) (Previous: 29, Consensus: 29)

11:00 AM - Atlanta Fed GDPNow (Q4) (Previous: 3.5%, Consensus: 3.5%)

4:30 PM - API Crude Oil Stock Change (Nov/13) (Previous: 9M)

Fed Speakers: Musalem 7:30 AM · Waller 9:20 AM · Hammack 9:30 AM · Williams 2:25 PM

IPOs Today

N/A

Biotech Calendar

XBI -7.02% on the week and +1.08% on the month, under its 50-day.

Upcoming: Sun 22 Nov · CAPR (Capricor Therapeutics, Inc.) · PDUFA
Fri 27 Nov · BBIO (BridgeBio Pharma, Inc.) · PDUFA · BBP-418

Note: Never front-run biotech catalysts. Wait for the catalyst to hit, then assess if the reaction is tradable. Dates are estimates and can shift.

Full H2 Biotech Watchlist: TradingView

Have a Great Day!

Sean Sharpe